S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

NBY NovaBay Pharmaceuticals Inc New

0.5399

0.00 (0.00%)

Pre Market

Last Updated: 05:09:57

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more NovaBay Pharmaceuticals Charts.

NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more NovaBay Pharmaceuticals Charts.

NovaBay Pharmaceuticals Inc New News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Wednesday 11 December 2024 (7 days ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 9 December 2024 (1 week ago) • Edgar (US Regulatory)

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
Monday 9 December 2024 (1 week ago) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 26 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 22 November 2024 (4 weeks ago) • Edgar (US Regulatory)

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
Friday 22 November 2024 (4 weeks ago) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
Friday 15 November 2024 (1 month ago) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

More NovaBay Pharmaceuticals Inc New News Articles

Tonix Pharmaceuticals

TPT Global Tech (CE)

GBT Technologies (PK)

Digital Brand Media and ... (PK)

Northwest Biotherapeutics (QB)

Clean Vision (QB)

Moon Equity (PK)

NioCorp Developments

Decentral Life (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions